Literature DB >> 22778451

An atypical case of purple glove syndrome: an avoidable adverse event.

Hanaa Rajabally1, Sathiji Nageshwaran, Sabina Russell.   

Abstract

A 73-year-old man presented in status epilepticus. He had a long history of epilepsy for which he was treated with regular phenytoin and phenobarbitone. On admission, his phenytoin level was found to be subtherapeutic and was treated with rectal diazepam and intravenous lorazepam. He was later started on an infusion of phenytoin in preparation to restart his oral medication. The medication was delivered via a peripheral cannula in his forearm. Five days later, he developed redness and swelling of this arm followed by the appearance of a large ulcer. After ruling out infective causes and a compartment syndrome it was felt that the patient had developed a delayed purple glove syndrome secondary to intravenous phenytoin. Following 7 days of regular saline irrigation and dressing changes, the erythema improved and the ulcer showed signs of healing, and eventually resolved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22778451      PMCID: PMC3416986          DOI: 10.1136/bcr.01.2012.5653

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  8 in total

1.  Extravasation injury of the upper extremity by intravenous phenytoin.

Authors:  Johnathan J Edwards; Voytek Bosek
Journal:  Anesth Analg       Date:  2002-03       Impact factor: 5.108

2.  Cost-minimization analysis of phenytoin and fosphenytoin in the emergency department.

Authors:  D R Touchette; D H Rhoney
Journal:  Pharmacotherapy       Date:  2000-08       Impact factor: 4.705

3.  Purple glove syndrome: a complication of intravenous phenytoin.

Authors:  D R Hanna
Journal:  J Neurosci Nurs       Date:  1992-12       Impact factor: 1.230

Review 4.  Guidelines for nonemergency use of parenteral phenytoin products: proceedings of an expert panel consensus process. Panel on Nonemergency Use of Parenteral Phenytoin Products.

Authors:  P D Meek; S N Davis; D M Collins; B E Gidal; P A Rutecki; A H Burstein; J H Fischer; I E Leppik; R E Ramsay
Journal:  Arch Intern Med       Date:  1999 Dec 13-27

5.  Recent and future advances in the treatment of status epilepticus.

Authors:  Felix Rosenow; Susanne Knake
Journal:  Ther Adv Neurol Disord       Date:  2008-07       Impact factor: 6.570

6.  A prospective study of the incidence of the purple glove syndrome.

Authors:  J G Burneo; J V Anandan; G L Barkley
Journal:  Epilepsia       Date:  2001-09       Impact factor: 5.864

7.  Early histopathologic changes in purple glove syndrome.

Authors:  Pradip Bhattacharjee; Earl J Glusac
Journal:  J Cutan Pathol       Date:  2004-08       Impact factor: 1.587

8.  Incidence and clinical consequence of the purple glove syndrome in patients receiving intravenous phenytoin.

Authors:  T J O'Brien; G D Cascino; E L So; D R Hanna
Journal:  Neurology       Date:  1998-10       Impact factor: 9.910

  8 in total
  2 in total

Review 1.  Purple Glove Syndrome after Phenytoin or Fosphenytoin Administration: Review of Reported Cases and Recommendations for Prevention.

Authors:  Lyudmila A Garbovsky; Byron C Drumheller; Jeanmarie Perrone
Journal:  J Med Toxicol       Date:  2015-12

2.  Purple Glove Syndrome: Recognizing a Rare Complication of Intravenous Phenytoin.

Authors:  Genesis Perez Del Nogal; Alyssa Rodaniche; Sailaja Devi Saragadam
Journal:  Cureus       Date:  2022-04-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.